Crohn's Disease Clinical Trials

Showing 281-300 of 1,088 trials

Microbial Community Characteristics in Intestinal Mucosal Tissue of Patients With CD

NCT06895772

The characteristics of the intestinal microbiota in Crohn's disease and their relationship with disease pathogenesis have not yet been fully elucidated. Therefore, this study aims to analyze the microbial community characteristics in the intestinal mucosal tissue of Crohn's disease patients and fill this knowledge gap. Additionally, this research holds significant importance for understanding the etiology of Crohn's disease and predicting treatment outcomes.

Crohn's Disease (CD)

Shandong University50 participantsStarted Nov 2024

Jinan, Shandong, China

COMPLETED

Infliximab Biosimilar "Pfizer" Drug Use Investigation (Crohn's Disease or Ulcerative Colitis)

NCT03884439

To collect information on the safety and effectiveness of Infliximab BS for Intravenous Drip Infusion 100 mg "Pfizer" against Crohn's disease or ulcerative colitis under actual status of use.

Crohn's DiseaseUlcerative Colitis

Pfizer428 participantsStarted Mar 2019

Tokyo, Japan

Active Not RecruitingNA

Changing the Future of Intestinal Failure in Intestinal Chronic Inflammation (INT-FAIL)

NCT06777251

This is an interventional, prospective, no profit study that will be performed at CEMAD, from FONDAZIONE POLICLINICO GEMELLI IRCCS, Rome (UO1) and U.O.C. Internal Medicine and Gastroenterology from Ospedale Brotzu di Cagliari (UO4). Adult patients with Crohn Disease (CD) and chronic intestinal insufficiency (CF) and adult patients with CD at high and low risk of CF.

Intestinal FailureInflammatory Bowel DiseasesCrohn Disease

Fondazione Policlinico Universitario Agostino Gemelli IRCCS254 participantsStarted Feb 2024

Roma, Italy

Microbial Community Characteristics in Intestinal Mucosal Tissue of Patients With CD

Infliximab Biosimilar "Pfizer" Drug Use Investigation (Crohn's Disease or Ulcerative Colitis)

Changing the Future of Intestinal Failure in Intestinal Chronic Inflammation (INT-FAIL)

Related Searches

Impact of Hepatitis B Virus on Inflammatory Bowel Disease

Ibd CAncer and seRious Infections in France (I-CARE 2)

Spatially and Temporally Resolving Predictive Biomarkers of Postoperative Recurrence and Complications in Chronic Intestinal Inflammation

Ganglioside and IBD

Changes in Faecal Calprotectin Levels and Participation-related Scores Following Three Weeks of Inpatient Rehabilitation

Non-invasive Vagus Nerve Stimulation in the Treatment of Crohn's Disease - A Pilot Study

Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease

Metformin as Added on Therapy in Patients With Ulcerative Colitis

PROactive and Early Infliximab Monitoring and OPTimization in Inflammatory Bowel Disease

Evaluation of an Anti-TREM-1 Treatment on an ex Vivo Human Intestinal Model

Observational Pharmaco-Epidemiology Research & Analysis

Role of IL 12 and IL 23 as Potential Biomarkers in Diagnosis of Early Crohn's Disease

A Study to Test Whether Spesolimab Helps People With Crohn's Disease Who Have Symptoms of Bowel Obstruction

Shingrix Vaccine in Patients With Moderate to Severe Ulcerative Colitis on Tofacitinib

Reliability of IUS in Crohn's Disease

Use of Psychologist-administered Cognitive Behavioral Therapy (CBT) or Self-administered CBT for the Treatment of Anxiety and/or Depression in Inflammatory Bowel Disease (IBD)

The Microbial Impact on Intestinal Fibrosis and the Associated Immune Microenvironment in Crohn's Disease